UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047382
Receipt number R000054043
Scientific Title Patient registry of hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P)
Date of disclosure of the study information 2022/04/04
Last modified on 2024/04/05 09:36:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Patient registry of hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P)

Acronym

HOPE-net

Scientific Title

Patient registry of hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P)

Scientific Title:Acronym

HOPE-net

Region

Japan


Condition

Condition

Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P)

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Investigate the natural, biomarker, clinical and therapeutic history of HMSN-P patients by cross-sectional and prospective study

Basic objectives2

Others

Basic objectives -Others

Cross-sectional study
Prospective cohort study

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Mortality and cause of death

Key secondary outcomes

Timing of introduction of invasive artificial ventilation

Time to cannot walk on its own

ALS Functional Rating Scale (ALSFRS-R)


Modified Ranking Scale (mRS)

EQ-5D-5L score


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) HMSN-P diagnosed or suspected case
(2) Patients signed the informed consent document

Key exclusion criteria

Patients considered unsuitable for participation in the study by the investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yoshihisa
Middle name
Last name Yamano

Organization

St. Marianna University School of Medicine

Division name

Department of Neurology

Zip code

216-8511

Address

2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8512 Japan

TEL

044-977-8111

Email

yyamano@marianna-u.ac.jp


Public contact

Name of contact person

1st name Naoko
Middle name
Last name Yagishita

Organization

Institute of Medical Science

Division name

None

Zip code

216-8512

Address

2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8512 Japan

TEL

044-977-8111

Homepage URL


Email

yagi@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

St. Marianna University School of Medicine

Address

2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8512 Japan

Tel

044-977-8111

Email

k-sienbu.mail@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

聖マリアンナ医科大学(神奈川県)


Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 12 Month 10 Day

Date of IRB

2022 Year 03 Month 01 Day

Anticipated trial start date

2022 Year 03 Month 01 Day

Last follow-up date

2035 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Design: cohort study


Management information

Registered date

2022 Year 04 Month 04 Day

Last modified on

2024 Year 04 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054043


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name